Krebs Biochemicals and Industries Limited — Board Meeting, 04-02-2025: Outcome of Board Meeting

The Board of Directors has announced a board meeting, where they approved the unaudited financial results for the third quarter and nine months ending December 31, 2024. Key figures include total income of ₹3,758.23 crore, with a net loss of ₹1,867.09 crore for the period. Additionally, the Board appointed four new independent directors, effective February 4, 2025, subject to shareholder approval. The committees of the Board have also been reconstituted to include these new appointments, which may enhance governance and strategic oversight going forward.